Drug Infusion Systems Market Driven by Rising Chronic Disease Prevalence and Technological Advancements

Drug infusion systems are medical devices designed to deliver medications, fluids, or nutrients directly into a patient's bloodstream or specific body sites. These systems offer precise control over dosage, timing, and delivery rates, ensuring optimal therapeutic outcomes and patient safety. Drug infusion systems are widely used in hospitals, clinics, and home healthcare settings for various treatments, including pain management, chemotherapy, diabetes management, and antibiotic therapy.

According to CoherentMI, The drug infusion system market is estimated to be valued at USD 13.93 Bn in 2025 and is expected to reach USD 25.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Key Takeaways:

Key players operating in the Drug Infusion Systems Market are
• Becton, Dickinson and Company,
• Baxter International, Inc.,
• ICU Medical, Inc.,
• B. Braun Melsungen AG,
• Fresenius Kabi AG, Medtronic plc,
• Smiths Medical,
• Terumo Corporation,
• Moog Inc.,
• F. Hoffmann-La Roche Ltd.
These companies are focusing on product innovation, strategic partnerships, and geographical expansion to strengthen their market position and cater to the growing demand for drug infusion systems worldwide.

Drug Infusion Systems Market
https://www.coherentmi.com/ind....ustry-reports/drug-i